Drug Profile
Cypemycin
Alternative Names: MW 2094Latest Information Update: 15 Mar 2007
Price :
$50
*
At a glance
- Originator Taiho Pharmaceutical
- Class Antibacterials; Bacteriocins; Biological peptides; Peptide antibiotics
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Cancer
Most Recent Events
- 15 Mar 2007 Discontinued - Preclinical for Bacterial infections in Japan (unspecified route)
- 15 Mar 2007 Discontinued - Preclinical for Cancer in Japan (unspecified route)
- 18 May 2001 No-Development-Reported for Bacterial infections in Japan (Unknown route)